PositoAI

a positivity index

Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights

Latest News

Standard BioTools Inc.

STANDARD BIOTOOLS INC. SEC Filing (Oct 22, 2026)
Stock Titan · 22 Oct 2026
Standard (LAB) Suffers -1.07% Decline on Heavy Selling 2026-10-20 - Pullback Trade
https://www.siam.in/ · 20 Oct 2026
Standard BioTools to Sell Microfluidics Business to Archimed
GenomeWeb · 06 Oct 2026
Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED
GlobeNewswire · 05 Oct 2026
Standard BioTools sells Microfluidics unit to ARCHIMED
Investing.com · 05 Oct 2026
Standard BioTools to sell Microfluidics business to ARCHIMED
TradingView · 05 Oct 2026
Standard Biotools Announces Agreement To Sell Microfluidics Business To Archimed
TradingView · 05 Oct 2026
A healthcare-focused investor agrees to buy Microfluidics from Standard BioTools (LAB).
Stock Titan · 05 Oct 2026
Standard BioTools Inks New Agreement to Sell Mass Cytometry Business for $5.5M
GenomeWeb · 01 Oct 2026
Standard BioTools to Sell Mass Cytometry Business to Element Biosystems for $5.5 Million
TradingView · 30 Sep 2026
Standard BioTools switches Mass Cytometry buyer to Element for $5.5M
Investing.com · 30 Sep 2026
Form 4 Standard Biotools Inc For: 30 September By Investing.com
Investing.com Canada · 30 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.